Non-Hodgkin lymphoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non-Hodgkin lymphoma}} | {{Non-Hodgkin lymphoma}} | ||
{{CMG}}; {{AE}} {{Preeti}} | |||
==Overview== | |||
[[PET]] and [[bone scan]] may be helpful in the diagnosis of non-Hodgkin lymphoma. | |||
==Other Imaging Findings== | |||
===PET Scan=== | |||
'''Indications''' | |||
*For identification of areas in the body that are affected by non-Hodgkin lymphoma<ref name="pmid19617723">{{cite journal| author=von Falck C, Rodt T, Joerdens S, Waldeck S, Kiesel H, Knapp WH et al.| title=F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. | journal=Clin Nucl Med | year= 2009 | volume= 34 | issue= 8 | pages= 493-5 | pmid=19617723 | doi=10.1097/RLU.0b013e3181abb6ba | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617723 }} </ref><ref name="pmid20960498">{{cite journal| author=Zinzani PL, Gandolfi L, Broccoli A, Argnani L, Fanti S, Pellegrini C et al.| title=Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. | journal=Cancer | year= 2011 | volume= 117 | issue= 5 | pages= 1010-8 | pmid=20960498 | doi=10.1002/cncr.25579 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20960498 }} </ref> | |||
*To help monitor response to treatment | |||
*For detection of recurrences | |||
===Bone Scan=== | |||
'''Indications''' | |||
*To see if non-Hodgkin lymphoma has spread to the bones | |||
*If bone pain is present (may be caused by bone involvement) | |||
*If [[alkaline phosphatase]] is increased | |||
===Multiple Gated Acquisition Scanning=== | |||
*A multiple gated acquisition scan should be performed to check for left ventricular ejection fraction (LVEF) of patients before starting treatment with anthracyclines. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[ | |||
[[ | |||
[[ | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category: | [[Category:Immunology]] | ||
Latest revision as of 21:05, 20 January 2019
|
Non-Hodgkin lymphoma Microchapters |
|
Differentiating Non-Hodgkin's Lymphoma |
|---|
|
Treatment |
|
Case Studies |
|
Non-Hodgkin lymphoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Non-Hodgkin lymphoma other imaging findings |
|
Risk calculators and risk factors for Non-Hodgkin lymphoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Overview
PET and bone scan may be helpful in the diagnosis of non-Hodgkin lymphoma.
Other Imaging Findings
PET Scan
Indications
- For identification of areas in the body that are affected by non-Hodgkin lymphoma[1][2]
- To help monitor response to treatment
- For detection of recurrences
Bone Scan
Indications
- To see if non-Hodgkin lymphoma has spread to the bones
- If bone pain is present (may be caused by bone involvement)
- If alkaline phosphatase is increased
Multiple Gated Acquisition Scanning
- A multiple gated acquisition scan should be performed to check for left ventricular ejection fraction (LVEF) of patients before starting treatment with anthracyclines.
References
- ↑ von Falck C, Rodt T, Joerdens S, Waldeck S, Kiesel H, Knapp WH; et al. (2009). "F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound". Clin Nucl Med. 34 (8): 493–5. doi:10.1097/RLU.0b013e3181abb6ba. PMID 19617723.
- ↑ Zinzani PL, Gandolfi L, Broccoli A, Argnani L, Fanti S, Pellegrini C; et al. (2011). "Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma". Cancer. 117 (5): 1010–8. doi:10.1002/cncr.25579. PMID 20960498.